Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal CancerJianxia Li, Yanhong Deng, Xianrui Wu et al.|Clinical Cancer Research|2023Cited by 33
Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapyGe Qin, Yanhong Deng, Fan Bai et al.|Molecular Medicine|2024Cited by 21